Glenohumeral Osteoarthritis
18
3
5
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
5.6%
1 terminated out of 18 trials
83.3%
-3.2% vs benchmark
22%
4 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
Prosthesis Versus Active Exercise Program in Patients With Glenohumeral Osteoarthritis
Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis
Poly vs Hybrid Glenoid in Stemless aTSA
Pyrocarbon Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis
ZILRETTA in Subjects With Shoulder Osteoarthritis
Anatomic Versus Reverse Shoulder Arthroplasty for Primary Glenohumeral Osteoarthritis
Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis
Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:
Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.
Osteoarthritis Shoulder Injection Study
Comparison of Stemless and Stemmed Shoulder Arthroplasty for Osteoarthritis
3D MR Versus 3D CT for Glenohumeral Arthritis
A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Adipose-derived Mesenchymal Stem Cells in Osteoarthritis
Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis
ORTHOVISC Shoulder Osteoarthritis Study
Objective Evaluation of Shoulder Pathology and Surgery